Gt Biopharma Inc. buy krebskrebs
Start price
03.01.22
/
50%
€2.70
Target price
03.01.23
€8.00
Performance (%)
-63.33%
End price
04.01.23
€0.99
Summary
This prediction ended on 04.01.23 with a price of €0.99. The BUY prediction by krebskrebs for Gt Biopharma Inc. performed very badly with a performance of -63.33%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Gt Biopharma Inc. | - | - | - |
iShares Core DAX® | 0.961% | -2.210% | 12.839% |
iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% |
iShares Nikkei 225® | 0.217% | -7.216% | 19.425% |
iShares S&P 500 | 1.540% | -1.858% | 27.801% |
Comments by krebskrebs for this prediction
In the thread Gt Biopharma Inc. diskutieren
Buy mit Kursziel 8,0
In the thread Trading Gt Biopharma Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten